Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24094768

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2014 Jan 4
First author
Fuchs CS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2014 Jan 4;383(9911):4-6. doi: 10.1016/S0140-6736(13)61892-9.
    note
    Source null
    related pmid
    24094766
    relationship
    Comment in
  2. citation
    Nat Rev Gastroenterol Hepatol. 2013 Dec;10(12):694. doi: 10.1038/nrgastro.2013.202.
    note
    Source null
    related pmid
    24126559
    relationship
    Comment in

Authors and identifiers

  1. name
    Fuchs CS
    type
    Author
  2. name
    Tomasek J
    type
    Author
  3. name
    Yong CJ
    type
    Author
  4. name
    Dumitru F
    type
    Author
  5. name
    Passalacqua R
    type
    Author
  6. name
    Goswami C
    type
    Author
  7. name
    Safran H
    type
    Author
  8. name
    Dos Santos LV
    type
    Author
  9. name
    Aprile G
    type
    Author
  10. name
    Ferry DR
    type
    Author
  11. name
    Melichar B
    type
    Author
  12. name
    Tehfe M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fuchs CS
    type
    Author
  2. name
    Tomasek J
    type
    Author
  3. name
    Yong CJ
    type
    Author
  4. name
    Dumitru F
    type
    Author
  5. name
    Passalacqua R
    type
    Author
  6. name
    Goswami C
    type
    Author
  7. name
    Safran H
    type
    Author
  8. name
    Dos Santos LV
    type
    Author
  9. name
    Aprile G
    type
    Author
  10. name
    Ferry DR
    type
    Author
  11. name
    Melichar B
    type
    Author
  12. name
    Tehfe M
    type
    Author
bibliography ids
  1. nci-bib-c53cbdea96d839291a79ab0e
book metadata
content sha256
d1ae95128ae2f57d78f6258b9c4519f63f7f2ae5a8582ac36459e11ef034bf0f
document type
citation
dois
  1. 10.1016/S0140-6736(13)61719-5
electronic publication date
display
2013 Oct 3
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24094768
immutable id
pubmed:24094768@d1ae95128ae2f57d78f6258b9c4519f63f7f2ae5a8582ac36459e11ef034bf0f
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9911
name
Lancet (London, England)
nlm unique id
2985213R
pages
31-39
volume
383
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2014 Jan 4;383(9911):4-6. doi: 10.1016/S0140-6736(13)61892-9.
    note
    Source null
    related pmid
    24094766
    relationship
    Comment in
  2. citation
    Nat Rev Gastroenterol Hepatol. 2013 Dec;10(12):694. doi: 10.1038/nrgastro.2013.202.
    note
    Source null
    related pmid
    24126559
    relationship
    Comment in
outcomes validated
false
pmid
24094768
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
bfcc566004024f47399a0413d4781c5977240b0d00a34e42b5308b0b6c136f3c
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2014 Jan 4
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24094768/
title
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Preserved source evidence · Not medical advice